Entrepreneur and Aspen founder Stephen Saad feels vindicated in his quest to expand and build the sterile capacity that allows him to produce Johnson & Johnson’s vaccine on the African continent.

Saad told investors during the pharma group’s first-half results webinar that its Gqeberha (formerly Port Elizabeth) production facility was built with vaccines in mind. As a result, no adjustments to the manufacturing site have been necessary, in contrast with other plants abroad that have had to retool their facilities to make Covid-19 vaccines...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now